In a significant move for both Veeva Systems Inc. (NYSE: VEEV) and UCB, the companies announced today that UCB will unify its global pharmacovigilance operations using the Veeva Safety Suite. This strategic partnership is aimed at maximizing operational efficiency, accelerating case processing, and streamlining submissions to health authorities through a single, standardized safety platform.

1. A Transformative Step for UCB

Jonas Maselis, head of digital technology and patient safety at UCB, emphasized the importance of this transition, stating, "Moving our teams onto Veeva Safety Suite is a core step in UCB's safety transformation, helping streamline global and local workflows with a single source of truth for safety data." This move is not merely about technology; it represents a comprehensive transformation in how UCB manages its safety data, enabling the company to leverage automation for low-touch case processing.

2. Features of Veeva Safety Suite

UCB will utilize the full suite of Veeva Safety solutions, which include:

Veeva Safety: This component will streamline the intake, processing, and submission of adverse events, ensuring a more efficient workflow.

Veeva SafetyDocs: Designed to manage all safety-related content and processes, this tool will ensure that documentation is organized and easily accessible.

Veeva Safety Workbench: This advanced data analysis platform allows for fast and scalable reporting, enabling UCB to respond swiftly to safety concerns.

Veeva Safety Signal: By automating signal detection, this feature enhances visibility and alignment across the organization, ensuring that safety signals are acted upon promptly.

Veeva Safety-RIM Connection: This integration will facilitate the automatic sharing of product information across regulatory and safety operations, contributing to cleaner and more trusted data.

3. Enhancing Global Compliance and Automation

John Lawrie, Vice President of Veeva Safety, noted that UCB is laying a strong foundation with the Veeva Safety Suite. He stated, "With a unified and connected approach, UCB is enhancing global compliance and driving advanced automation to deliver safe and effective medicines to patients." This partnership not only aims to improve internal processes but also seeks to enhance the regulatory compliance necessary for the pharmaceutical industry.

4. About Veeva Systems

Veeva Systems is recognized as a leader in providing cloud-based solutions tailored for life sciences. With a commitment to innovation and excellence, Veeva serves over 1,500 customers, ranging from large pharmaceutical firms to emerging biotech companies. The company's dedication to balancing the interests of all stakeholders—customers, employees, and shareholders—positions it as a public benefit corporation focused on creating value across the industry.

5. Conclusion

The partnership between UCB and Veeva Systems marks a pivotal moment in the evolution of pharmacovigilance operations. As UCB embraces Veeva's advanced safety suite, the potential for enhanced efficiency, compliance, and patient safety appears promising. This collaboration not only sets a benchmark for the industry but also signifies the growing importance of technology in the realm of pharmaceutical safety management.

Original press release